Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENZALUTAMIDE Cause Poor quality product administered? 38 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Poor quality product administered have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.

38
Reports of Poor quality product administered with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
1
Deaths
4
Hospitalizations

How Dangerous Is Poor quality product administered From ENZALUTAMIDE?

Of the 38 reports, 1 (2.6%) resulted in death, 4 (10.5%) required hospitalization.

Is Poor quality product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does ENZALUTAMIDE Cause?

Fatigue (8,891) Death (6,680) Malignant neoplasm progression (4,696) Prostatic specific antigen increased (3,731) Asthenia (3,589) Drug ineffective (3,468) Hot flush (3,144) Decreased appetite (3,069) Nausea (2,898) Dizziness (2,776)

What Other Drugs Cause Poor quality product administered?

ONABOTULINUMTOXINA (495) ICOSAPENT ETHYL (452) MINOXIDIL (428) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (376) ADALIMUMAB (239) TESTOSTERONE CYPIONATE (235) SOMATROPIN (234) POLYETHYLENE GLYCOL 3350 (223) IBUPROFEN (222) INSULIN GLARGINE (133)

Which ENZALUTAMIDE Alternatives Have Lower Poor quality product administered Risk?

ENZALUTAMIDE vs EPCORITAMAB ENZALUTAMIDE vs EPCORITAMAB-BYSP ENZALUTAMIDE vs EPERISONE ENZALUTAMIDE vs EPHEDRINE ENZALUTAMIDE vs EPINASTINE

Related Pages

ENZALUTAMIDE Full Profile All Poor quality product administered Reports All Drugs Causing Poor quality product administered ENZALUTAMIDE Demographics